| Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment Q Haas, KF Boligan, C Jandus, C Schneider, C Simillion, MA Stanczak, ... Cancer immunology research 7 (5), 707-718, 2019 | 110 | 2019 |
| The distinct roles of sialyltransferases in cancer biology and onco-immunology M Hugonnet, P Singh, Q Haas, S von Gunten Frontiers in immunology 12, 799861, 2021 | 56 | 2021 |
| Reducing systematic review burden using Deduklick: a novel, automated, reliable, and explainable deduplication algorithm to foster medical research N Borissov, Q Haas, B Minder, D Kopp-Heim, M von Gernler, H Janka, ... Systematic Reviews 11 (1), 172, 2022 | 31 | 2022 |
| A cartography of siglecs and sialyltransferases in gynecologic malignancies: is there a road towards a sweet future? Q Haas, C Simillion, S Von Gunten Frontiers in oncology 8, 68, 2018 | 17 | 2018 |
| Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities Q Haas, N Markov, L Muerner, V Rubino, A Benjak, M Haubitz, ... Frontiers in immunology 13, 996746, 2022 | 11 | 2022 |
| Utilizing artificial intelligence to manage COVID-19 scientific evidence torrent with risklick ai: a critical tool for pharmacology and therapy development Q Haas, DV Alvarez, N Borissov, S Ferdowsi, L von Meyenn, S Trelle, ... Pharmacology 106 (5-6), 244-253, 2021 | 9 | 2021 |
| Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection M Brügger, T Démoulins, GT Barut, B Zumkehr, BI Oliveira Esteves, ... PLoS pathogens 17 (7), e1009789, 2021 | 7 | 2021 |
| Ensemble of deep learning language models to support the creation of living systematic reviews for the COVID-19 literature J Knafou, Q Haas, N Borissov, M Counotte, N Low, H Imeri, AM Ipekci, ... Systematic reviews 12 (1), 94, 2023 | 3 | 2023 |
| Vaccine development in the time of COVID-19: the relevance of the Risklick AI to assist in risk assessment and optimize performance Q Haas, N Borisov, DV Alvarez, S Ferdowsi, L von Meyenn, D Teodoro, ... Frontiers in digital health 3, 745674, 2021 | 3 | 2021 |
| 21P Duration of breast cancer trials: Analysis of predicted versus actual completion date D Verschoor, P Khlebnikov, F Meer, P Amini, Q Haas, E Segelov Annals of Oncology 34, S1475, 2023 | | 2023 |
| Scientific Evidence Management System: Proof of concept for COVID-19 L von Meyenn, D Teodoro, N Borissov, S Ferdows, M Counotte, Q Haas, ... EXPERIMENTAL DERMATOLOGY 30 (3), E46-E47, 2021 | | 2021 |
| 47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF): Virtual, March 04-06, 2021. L von Meyenn, D Teodoro, N Borissov, S Ferdows, M Counotte, Q Haas, ... Exp Dermatol, e1-e135, 2021 | | 2021 |
| The Role of Siglec-7 and Siglec-9 on Cytotoxic T Cells Q Haas Faculty of Medicine of the University of Bern, 2020 | | 2020 |
| Glycan-Checkpoint Inhibitor unleashing CD8+ T cells against Cancer Q Haas, C Schneider, K Boligan, C Simillion, C Jandus, G Baerlocher, ... SWISS MEDICAL WEEKLY 148, 37S-38S, 2018 | | 2018 |
| Siglec-7 and-9 receptors on cytotoxic T cells and their impact on anti-tumor immune responses Q Haas, C Schneider, C Jandus, M Haubitz, MT Tankica, L Sarah, ... SWISS MEDICAL WEEKLY 147, 61S-61S, 2017 | | 2017 |
